Literature DB >> 18367745

Cardiac connections--the antiarrhythmic solution?

Heather S Duffy1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18367745     DOI： 10.1056/NEJMcibr0708922

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.

Authors:  Elke De Vuyst; Kerstin Boengler; Gudrun Antoons; Karin R Sipido; Rainer Schulz; Luc Leybaert
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype.

Authors:  Jorge Massare; Jeff M Berry; Xiang Luo; Farhana Rob; Janet L Johnstone; John M Shelton; Rhonda Bassel-Duby; Joseph A Hill; R Haris Naseem
Journal:  J Cardiovasc Electrophysiol       Date:  2010-09

3.  Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy.

Authors:  Vassilis Dimas; Colby Ayers; James Daniels; Jose A Joglar; Joseph A Hill; R Haris Naseem
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

4.  Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction.

Authors:  Leonardo Bocchi; Monia Savi; Gallia Graiani; Stefano Rossi; Aldo Agnetti; Francesca Stillitano; Costanza Lagrasta; Silvana Baruffi; Roberta Berni; Caterina Frati; Mario Vassalle; Umberto Squarcia; Elisabetta Cerbai; Emilio Macchi; Donatella Stilli; Federico Quaini; Ezio Musso
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 5.  Stem cells can form gap junctions with cardiac myocytes and exert pro-arrhythmic effects.

Authors:  Nicoline W Smit; Ruben Coronel
Journal:  Front Physiol       Date:  2014-10-29       Impact factor: 4.566
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.